Q4 2024 Holdings
Filed 2025-02-14 | 15 holdings | $16.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $6.8M | 2,015,157 | 41.1% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $6.5M | 1,318,967 | 38.8% |
| Spdr S&P 500 ETF TR(SPY) | TR UNIT | 78462F103 | $1.7M | 2,823 | 9.9% |
| Berkshire Hathaway Inc del(BRK/B) | CL B NEW | 084670702 | $513.6K | 1,133 | 3.1% |
| Spdr Gold TR(GLD) | GOLD SHS | 78463V107 | $283.1K | 1,169 | 1.7% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $237.1K | 34,073 | 1.4% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $190.6K | 10,941 | 1.1% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $117.5K | 17,851 | 0.7% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $86.0K | 22,981 | 0.5% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $63.0K | 43,465 | 0.4% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $57.7K | 13,287 | 0.3% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $53.3K | 16,393 | 0.3% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $50.9K | 203,578 | 0.3% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $19.3K | 18,403 | 0.1% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $16.8K | 17,488 | 0.1% |